About Fecal Parasite Testing:

A fecal exam, also called an ova and parasite test (O&P), is used to diagnose intestinal parasitic infection in companion animals such as dogs and cats. A fresh sample of stool must be collected and tested on the same day in order to detect the presence of fragile organisms which have a limited lifespan. O&P testing is performed during well visits to the veterinarian or when symptoms of infection are present.

Parasitic infection can have a serious impact on animals and humans alike. Parasitic infection can cause an animal to become very lethargic, and may result in diarrhea and weight loss. Some animals, particularly younger ones, can carry a large enough parasite load to cause death. Some parasites also carry a zoonotic risk (meaning they can be contagious to humans). This means fecal exams are not just necessary for healthy pets, they’re essential for healthy humans, too. The danger is greatest for very young children, very old adults or otherwise immuno-compromised family members.

The Companion Animal Parasite Council (CAPC) is an organization which “advocates best practices for protecting pets from parasitic infections and reducing the risk of zoonotic parasite transmission.” (http://www.petsandparasites.org/resources/pets-parasites-and-people). CAPC recommends that veterinarians perform fecal examinations every 6 months in adult dogs and cats, and at least four times during the first year of life. Kittens and puppies are more likely to be infected with intestinal parasites, so they are tested more frequently for parasitic infection.

Deworming is performed for pets who are diagnosed with parasitic infections. Since there are multiple classes of dewormers, it is important to identify the specific types of worms present in order to treat them effectively. A method which allows both the detection and classification of parasite ova (eggs) is critical to proper treatment.

Generic placeholder image

About the Product: The Science Behind PARATEST®

PARATEST® is an exceptional product that utilizes passive sedimentation through a patented 266 micron filter. Our unique passive sedimentation technique eliminates the need for centrifugation and has been proven to provide accurate results for both heavy and light eggs and oocysts.

The simplified processing method paired with the fifteen day room temperature stability preserves the technician’s valuable time by allowing for the batching and testing of multiple samples.

With a specific gravity below 1.02 g/mL, the solution allows sedimentation of parasites and oocysts with variable densities to occur without interference. And, with the presence of our eco-friendly fixative, even the most delicate oocysts retain their morphology for a clear microscopic read.

About the Product

About DK Diagnostics: Creator of PARATEST®:

PARATEST® technology was developed and patented by Mr. Jose Carlos Lapenna, President and CEO of DK Diagnostics. PARATEST® contains a fixative solution for biological materials used with veterinary or human biological tissues, cells, organs and secretions, as well as bacteria, viruses and parasites. The product is patented in the United States and has been approved for veterinary in vitro diagnostics use.

DK Diagnostics is a global company operating in North America, Europe, Asia and South America. The company was founded in 2004 with the name of Diagnostek, designed to generate technology and simplify routines for laboratory examinations for both the public and the private sectors.

DK Diagnostics has partnered with a US company for exclusive rights to manufacture, sell and distribute PARATEST®. Bio-Techne –Devens will formulate, fill, test and package PARATEST® for the US, Canadian, and Mexican markets (North America).

Generic placeholder image

About Bio-Techne—Devens

Bio-Techne—Devens was incorporated as Bionostics in Acton, Massachusetts in 1981, and in 2001 relocated to its current state-of-the-art manufacturing facility located in Devens, Massachusetts. The organization has grown and evolved to become a worldwide leader in the development and manufacture of turnkey quality control products used in human in-vitro diagnostics. Bionostics was acquired by Bio-Techne, a corporation committed to building innovation opportunities, in 2013.

Bio-Techne—Devens has partnerships which range from collaborations with start-up companies to product development and feasibility projects for established organizations. We also have extensive experience at providing technology transfers to meet each customer’s unique requirements. Our focus on quality protects the integrity of the client company's brands and meets or exceeds all relevant regulatory requirements. The transfer of production for PARATEST® adheres to our robust quality system, which has been designed to conform to US FDA guidelines for human IVD products.

About the Product

About Bio-Techne Corporation:

Our parent company, Bio-Techne, brings its diverse expertise and the combined strengths of its product offerings to the research and diagnostic communities. As an established corporation with thousands of products in its portfolio, Bio-Techne Corporation employs over 1,650 employees worldwide. Bio-Techne has its roots in the American mid-west. Originally named Techne Corporation, it was incorporated in Minneapolis, Minnesota in 1981.

Several other subsidiaries of Bio-Techne, including R&D Systems (located in Minneapolis, MN), Biospacific (located in Emeryville, CA), and Cliniqa (located in San Marcos, CA), are engaged in the development, manufacture and sale of biotechnology products used for IVD testing. Together, we collectively operate as the Diagnostics Division of Bio-Techne.

Generic placeholder image